OEM News

Picard Medical Adds Connector Covers to SynCardia Artificial Heart

The additional design component is being incorporated into standard clinical practice for U.S. patients.

By: Michael Barbella

Managing Editor

SynCardia Total Artificial Heart. Photo: SynCardia, a Picard Medical Company.

Picard Medical Inc. has begun to incorporate an additional design component of its U.S. Food and Drug Administration (FDA)-cleared accessory—CPC1 “Connector Covers”—into the SynCardia Total Artificial Heart (STAH). The covers aim to provide comfort during daily activities while reinforcing system safety and reliability.

Specifically, the CPC Connector Covers offer extra protection over the metal release buttons found on the STAH CPC connectors, which externally connect SynCardia Drivers to the two pneumatic drive cannulas of the STAH ventricles. The rollout currently is being incorporated into standard clinical practice for U.S. patients.

“Patient safety and quality of life are central to everything we do,” SynCardia Senior Clinical Specialist Steve Langford said. “This enhancement reflects our ongoing commitment to practical improvements that support confidence and ease of use for both patients and clinicians.”

All SynCardia sales and clinical staff completed the required training. SynCardia will work directly with hospital and clinical teams to provide training materials, implementation guidance, and support for existing patients as appropriate.

Picard Medical Inc. is the parent company of SynCardia Systems LLC, ae Tucson, Ariz.–based firm with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (STAH), an implantable system that assumes the full functions of a failing or failed human heart. It is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada. With more than 2,100 implants performed at hospitals across 27 countries, the SynCardia Total Artificial Heart is the world’s most widely used and extensively studied artificial heart.

Reference
1 Cold Products Company, a part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in liquid cooling of electronics

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters